About Merrybell Bioceuticals
Merrybell Bioceuticals is a Healthcare company based in Karnal (India) founded in 2012. It manufactures and markets pharmaceutical products including tablets, capsules, and ointments worldwide. It operates on a B2B and D2C model. Its Indian entity Xieon Life Sciences Private Limited reported revenue of ₹43.18 Cr. Merrybell Bioceuticals offers products and services including Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Herbal and Ayurvedic. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
MerryBell, established in 2008 in India, specializes in manufacturing and marketing a wide range of pharmaceutical products such as tablets, capsules, ointments, syrups, and injections. The company serves various healthcare categories including general care, orthopedic, and dermatology, emphasizing quality, affordability, and global distribution. It operates from its primary location in Karnal, aiming to alleviate suffering through accessible medicines and innovative solutions for clients across the globe.
- Headquarters Karnal, India
- SectorsHealthcare
- Website merrybellbioceuticals.com
- Social YouTube
- Legal Name Xieonlife Sciences Pvt. Ltd.
- Date of Incorporation 14 Feb, 2007
- Jurisdiction Delhi, India
- Annual Revenue₹43.18 Cr
FY 2024 · +18% YoY
- Net Profit₹1.32 Cr
FY 2024 · 3% margin
- EBITDA₹2.15 Cr
FY 2024 · 5% margin
Associated legal entities of Merrybell Bioceuticals
Merrybell Bioceuticals operates through Xieon Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Xieon Life Sciences Private Limited CIN U51101DL2007PTC159289 | Active | 14 Feb 2007 | Delhi, Delhi | ₹43.2 Cr | 4 | View details |
Products & Services of Merrybell Bioceuticals
Merrybell Bioceuticals offers a comprehensive portfolio of products and services, including Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections.
Solid dosage forms for treating various health conditions effectively.
Encapsulated drugs providing targeted treatment for multiple ailments.
Creams and lotions for skin and derma care applications.
Oral liquids for easy administration in pediatric and general care.
Parenteral drugs for specialized treatments like diabetic care.
Apps and channels of Merrybell Bioceuticals
its YouTube channel XIEON LIFE SCIENCES PVT LTD. has 218 subscribers and 30 videos.
Videos from Merrybell Bioceuticals
The most watched videos on Merrybell Bioceuticals's YouTube channel, XIEON LIFE SCIENCES PVT LTD. (218 subscribers). Click a video to play it here.
More on XIEON LIFE SCIENCES PVT LTD..
Board of directors of Xieon Life Sciences Private Limited (Merrybell Bioceuticals)
Xieon Life Sciences Private Limited is the primary company behind Merrybell Bioceuticals. The board of Xieon Life Sciences Private Limited currently have 4 directors; the longest-serving is Ankur Goyal, appointed in 2007. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ankur Goyal DIN 02409564 | Director | 14 Feb 2007 | 19 yrs 8 mo | Xieon Life Sciences Private Limited |
| Yogesh Singla DIN 02409556 | Managing Director | 14 Feb 2007 | 19 yrs 8 mo | Xieon Life Sciences Private Limited |
| Ashok Bambha DIN 03158636 | Director | 01 May 2010 | 16 yrs 5 mo | Xieon Life Sciences Private Limited |
| Manoj Singla DIN 11347566 | Director | 10 Oct 2025 | 1 yr | Xieon Life Sciences Private Limited |
Financials of Merrybell Bioceuticals
Figures of Xieon Life Sciences Private Limited, the primary company behind Merrybell Bioceuticals, for FY 2024. Revenue was ₹43.18 Cr (+18% year on year). Net profit was ₹1.32 Cr (3% margin). EBITDA was ₹2.15 Cr (5% margin). Revenue has grown at a compounded annual rate of +7% over three years and +14% over five years.
- ₹43.18 CrRevenue · FY 2024 · +18% YoY
- ₹1.32 CrNet profit · 3% margin
- ₹2.15 CrEBITDA · 5% margin
- ₹2.00 CrPaid-up capital
- +7%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Xieon Life Sciences Private Limited are on its company page.
Detailed financial statements for Merrybell Bioceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Merrybell Bioceuticals
Merrybell Bioceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Merrybell Bioceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Merrybell Bioceuticals
Merrybell Bioceuticals was founded in 2012.
Merrybell Bioceuticals is headquartered in Karnal, India. It is registered at Karnal, Haryana, India.
The primary company behind Merrybell Bioceuticals, Xieon Life Sciences Private Limited, reported revenue of ₹43.18 Cr for FY 2024, up 18% year on year.
MerryBell, established in 2008 in India, specializes in manufacturing and marketing a wide range of pharmaceutical products such as tablets, capsules, ointments, syrups, and injections. The company serves various healthcare categories including general care, orthopedic, and dermatology, emphasizing quality, affordability, and global distribution. It operates from its primary location in Karnal, aiming to alleviate suffering through accessible medicines and innovative solutions for clients across the globe.
Merrybell Bioceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Merrybell Bioceuticals offers Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections.
Merrybell Bioceuticals operates through Xieon Life Sciences Private Limited.
The legal entities of Merrybell Bioceuticals currently have 4 directors, including Ashok Bambha, Ankur Goyal, Yogesh Singla and others.